vemurafenib

vemurafenib

美 　英

• 网络威罗菲尼；威罗菲尼片；维罗非尼

例句

Roche's vemurafenib attacks advanced melanoma by blocking the mutated form of a gene, B-RAF.

罗氏公司的vemurafenib通过阻断一种突变的基因B-RAF攻击晚期黑色素瘤。

One study presented at the American Society of Clinical Oncology's (ASCO) conference on Sunday focused on the experimental drug vemurafenib.

周日美国临床肿瘤学会召开的学术会议中一项针对试验用药vemurafenib的研究引起关注。

This month Roche submitted an application to the Food and Drug Administration (FDA) for a new melanoma drug, vemurafenib.

本月，罗氏（Roche）向食品及药物管理局（FDA）提交了一种黑素瘤药品vemurafenib。

In a large, phase 3 study involving 675 people worldwide, patients on vemurafenib did much better than those on chemotherapy.

在一项全球有675名病患参与的三组对照研究中，vemurafenib的疗效远高于化疗。

While patients taking vemurafenib do very well, Schuchter said the drug stops working after about nine or 10 months.

病患服用vemurafenib后效果良好，舒特说服药9-10个月药物才失效。

Vemurafenib blocks the mutated gene, which kills the cancer cell and shrinks tumors.

他强调vemurafenib阻断变异的基因，从而杀死肿瘤细胞令肿瘤萎缩。

Those taking vemurafenib had a 63% reduced risk of death compared to those on chemo.

与化疗组相比，vemurafenib组的病患死亡风险下降了63%。